Royal Bank Of Canada Gelesis Holdings, Inc. Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.11 - $0.52 $160 - $758	-1,459 Reduced 17.09%	7,076 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.22 - $0.51 $736 - $1,707	3,348 Added 64.55%	8,535 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.34 $410 - $6,876	5,132 Added 9330.91%	5,187 $5,000
Q2 2022 Aug 15, 2022	BUY	N/A	55 New	55 $0

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.